PDCD1 and malignant colon neoplasm: The survival of the BALB/c mouse colon cancer model was also monitored for 28 days, and the mice receiving both MS-20 and the anti-PD1 antibody had the highest survival rate compared to the vehicle control and anti-PD1 alone groups (Figure 1d).